CS253734B2 - Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid - Google Patents

Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid Download PDF

Info

Publication number
CS253734B2
CS253734B2 CS859449A CS944985A CS253734B2 CS 253734 B2 CS253734 B2 CS 253734B2 CS 859449 A CS859449 A CS 859449A CS 944985 A CS944985 A CS 944985A CS 253734 B2 CS253734 B2 CS 253734B2
Authority
CS
Czechoslovakia
Prior art keywords
tartaric acid
dobutamine
methylpropyl
ethylamine
salt
Prior art date
Application number
CS859449A
Other languages
Czech (cs)
English (en)
Inventor
Eddie H Massey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS253734B2 publication Critical patent/CS253734B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/06—Glycolic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/285—Polyhydroxy dicarboxylic acids having five or more carbon atoms, e.g. saccharic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Detergent Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
CS859449A 1984-12-20 1985-12-18 Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid CS253734B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68440484A 1984-12-20 1984-12-20

Publications (1)

Publication Number Publication Date
CS253734B2 true CS253734B2 (en) 1987-12-17

Family

ID=24747892

Family Applications (1)

Application Number Title Priority Date Filing Date
CS859449A CS253734B2 (en) 1984-12-20 1985-12-18 Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid

Country Status (24)

Country Link
EP (1) EP0187019B1 (pl)
JP (1) JPS61155355A (pl)
KR (1) KR870000803B1 (pl)
CN (1) CN1009922B (pl)
AT (1) ATE58370T1 (pl)
AU (1) AU589929B2 (pl)
CA (1) CA1254909A (pl)
CS (1) CS253734B2 (pl)
DD (1) DD241071A5 (pl)
DE (2) DE3580575D1 (pl)
DK (1) DK589385A (pl)
EG (1) EG17889A (pl)
ES (2) ES8705841A1 (pl)
FI (1) FI855018A (pl)
GR (1) GR853027B (pl)
HU (1) HU194805B (pl)
MY (1) MY104814A (pl)
NZ (1) NZ214583A (pl)
PH (1) PH22547A (pl)
PL (1) PL148296B1 (pl)
PT (1) PT81705B (pl)
RO (1) RO93391B (pl)
SU (1) SU1480761A3 (pl)
ZA (1) ZA859629B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
FR2740337B1 (fr) * 1995-10-27 1997-11-21 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees contenant un derive ayant une activite adrenergique
FR2740338B1 (fr) * 1995-12-01 1997-12-05 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees contenant de la dobutamine
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
CN105906515B (zh) * 2015-12-10 2018-03-13 菏泽市方明制药有限公司 一种盐酸多巴酚丁胺脱色工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
FR2333499A1 (fr) * 1975-12-01 1977-07-01 Roussel Uclaf Nouveau derive de la phenethylamine et ses sels, procede de preparation et application a titre de medicament

Also Published As

Publication number Publication date
RO93391A (ro) 1988-03-30
ATE58370T1 (de) 1990-11-15
PL256848A1 (en) 1986-10-21
JPH0327544B2 (pl) 1991-04-16
ZA859629B (en) 1987-07-29
PT81705A (en) 1986-01-01
CA1254909A (en) 1989-05-30
ES557426A0 (es) 1988-08-01
PH22547A (en) 1988-10-17
PL148296B1 (en) 1989-10-31
HU194805B (en) 1988-03-28
PT81705B (pt) 1988-04-21
MY104814A (en) 1994-04-30
EP0187019A2 (en) 1986-07-09
RO93391B (ro) 1988-03-31
KR860004834A (ko) 1986-07-14
ES8705841A1 (es) 1987-05-16
KR870000803B1 (ko) 1987-04-20
HUT40069A (en) 1986-11-28
FI855018A (fi) 1986-06-21
NZ214583A (en) 1989-04-26
DD241071A5 (de) 1986-11-26
AU589929B2 (en) 1989-10-26
SU1480761A3 (ru) 1989-05-15
AU5141585A (en) 1986-06-26
DE187019T1 (de) 1987-11-26
FI855018A0 (fi) 1985-12-17
CN1009922B (zh) 1990-10-10
EP0187019A3 (en) 1987-09-30
JPS61155355A (ja) 1986-07-15
ES550151A0 (es) 1987-05-16
CN85109229A (zh) 1986-10-01
DK589385A (da) 1986-06-21
DK589385D0 (da) 1985-12-18
ES8802570A1 (es) 1988-08-01
GR853027B (pl) 1986-04-18
EP0187019B1 (en) 1990-11-14
DE3580575D1 (en) 1990-12-20
EG17889A (en) 1991-03-30

Similar Documents

Publication Publication Date Title
US3266987A (en) Substituted thiourea compounds and methods of using same as anthelmintics
Hillman et al. The use of dicobalt edetate (Kelocyanor) in cyanide poisoning
US2848366A (en) Non-hydrated ferrous fumarate and hematinic composition thereof
CS253734B2 (en) Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid
DE4130061A1 (de) Furanderivate enthaltende pharmazeutische praeparate
US4151188A (en) Arsenamide compound
Dakin The behaviour of hypochlorites on intravenous injection and their action on blood serum
Harrison et al. THE REGULATION OF CIRCULATION: VIII. The Relative Importance of Nervous, Endocrine and Vascular Regulation in the Response of the Cardiac Output to Anoxemia
DE2034640C3 (de) l-p-(7-Trifluormethyl-4-chinolyl) -amino-benzoyl-piperazine, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Bluthochdruck
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
Hull et al. The antagonism of adrenergic blockade by dichloroisoproterenol (DCI)
Stanley et al. Cobalt polycythemia. II. Relative effects of oral and subcutaneous administration of cobaltous chloride
US3459854A (en) Tetracycline cyclohexyl sulphamate and process for preparation
US3138529A (en) Tetracycline antibiotic compositions for oral use
US2678899A (en) Stable solution of physostigmine
US3080288A (en) Oral compositions and method for increasing tetracycline antibiotic absorption with tartronic acid
DE3878494T2 (de) Mittel gegen zuckerkrankheit.
KONCHIGERI et al. Effect of epinephrine during enflurane anesthesia
Lannek et al. Toxicity of Halogenated Oxyquinolines in Dogs. A Clinical Study: III. Intoxication Experiments
CA1118353A (en) Pharmaceutical compositions comprising phenylglyoxylic acids
KR800000452B1 (ko) 벤젠설포닐-우레아의 제조방법
RU2021260C1 (ru) Соли акриловой кислоты, проявляющие цитопротекторную и противоязвенную активность, и состав, обладающий цитопротекторной и противоязвенной активностью
JPS6129324B2 (pl)
SU621148A1 (ru) Вещество, антикоагул нтную активность
US3679802A (en) Method of preventing convulsions